rs201746137
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_001164508.2(NEB):c.8039G>A(p.Arg2680Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000139 in 1,613,646 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001164508.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEB | ENST00000397345.8 | c.8039G>A | p.Arg2680Gln | missense_variant | Exon 58 of 182 | 5 | NM_001164508.2 | ENSP00000380505.3 | ||
NEB | ENST00000427231.7 | c.8039G>A | p.Arg2680Gln | missense_variant | Exon 58 of 182 | 5 | NM_001164507.2 | ENSP00000416578.2 | ||
NEB | ENST00000409198.5 | c.8039G>A | p.Arg2680Gln | missense_variant | Exon 58 of 150 | 5 | ENSP00000386259.1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152066Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000213 AC: 53AN: 249092Hom.: 1 AF XY: 0.000215 AC XY: 29AN XY: 135118
GnomAD4 exome AF: 0.000146 AC: 213AN: 1461580Hom.: 1 Cov.: 31 AF XY: 0.000149 AC XY: 108AN XY: 727062
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152066Hom.: 0 Cov.: 33 AF XY: 0.0000943 AC XY: 7AN XY: 74252
ClinVar
Submissions by phenotype
Nemaline myopathy 2 Uncertain:1Benign:1
- -
- -
Inborn genetic diseases Uncertain:1
The c.8039G>A (p.R2680Q) alteration is located in exon 58 (coding exon 56) of the NEB gene. This alteration results from a G to A substitution at nucleotide position 8039, causing the arginine (R) at amino acid position 2680 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at